10 results
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
; refusal to approve pending BLAs or BLA supplements that we submit; recall of our products; fines, restitution, or disgorgement of profits or revenue
ARS
2022 FY
CRBU
Caribou Biosciences Inc
28 Apr 23
Annual report to shareholders
12:00am
BLAs or BLA supplements that we submit; recall of our products; fines, restitution, or disgorgement of profits or revenue; suspension or withdrawal
10-K
2021 FY
CRBU
Caribou Biosciences Inc
21 Mar 22
Annual report
4:19pm
of warning or untitled letters;
withdrawal of our products from the market;
refusal to approve pending BLAs or BLA supplements that we submit;
recall of our
424B4
CRBU
Caribou Biosciences Inc
23 Jul 21
Prospectus supplement with pricing info
4:24pm
or untitled letters;
withdrawal of our products from the market;
refusal to approve pending BLAs or BLA supplements that we submit;
recall of our … include a warning letter or an injunction against shipment of products from the facility and/or recall of products previously shipped.
Review
S-1/A
90erin3o m1
19 Jul 21
IPO registration (amended)
6:09am
S-1
ey8yh4lxbtosv
1 Jul 21
IPO registration
4:05pm
DRS/A
n79c grp0m
11 Jun 21
Draft registration statement (amended)
12:00am
DRS
4271mz0splco dnfqmy
7 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next